Japan's Hisamitsu to buy Noven Pharm for $430 mln
TOKYO, July 14 (Reuters) - Japanese health goods maker Hisamitsu Pharmaceutical Co (4530.T) said on Tuesday it would buy Miami-based Noven Pharmaceuticals Inc (NOVN.O) for $430 million and would offer $16.50 for each Noven share. (Reporting by Mayumi Negishi)
© Thomson Reuters 2009 All rights reserved
Wall St meets "The Sopranos"
Details of an alleged insider trading ring read like the script of a mobster drama, full of coded nicknames, disposable cell phones and paranoia about informants. But in the end, all of the precautions were for naught. Full Article
